India's vaccine manufacturer, Bharat Biotech, announced a new collaboration with the University of Sydney Infectious Diseases Institute (Sydney ID) to advance vaccine research and development. The partnership aims to design innovative methodologies to tackle future epidemics and infectious diseases threats through strong academic-industry collaboration. Bharat Biotech and Sydney ID will...
India’s Own Covid-19 Vaccine is 81 Percent Effective
Yesterday, Hyderabad-based Bharat Biotech published interim results from the Phase 3 trial of it Covid-19 vaccine, branded as Covaxin. 25,8000 subjects participated in the trial. The trial found 43 cases of COVID-19 patients who showed symptoms ranging from mild to moderate and severe, and of the total cases, 36 were from...